[Resumption-inhibition in presynaptic action: the medicinal]

Pharm Unserer Zeit. 2004;33(4):282-7. doi: 10.1002/pauz.200400074.

[Article in German]

Authors

Manfred Schubert-Zsilavecz¹, Holger Stark

Affiliation

¹ Johann Wolfgang Goethe-Universität, Institute für Pharmazeutische Chemie, Frankfurt am Main. [email protected]

PMID: 15287688
DOI: 10.1002/pauz.200400074

No abstract available

Publication types

Review

MeSH terms

Adrenergic Uptake Inhibitors / pharmacology
Antidepressive Agents / pharmacokinetics
Antidepressive Agents / pharmacology*
Carrier Proteins / metabolism
Dopamine Plasma Membrane Transport Proteins
Drug Interactions
Humans
Membrane Glycoproteins / metabolism
Membrane Transport Proteins / metabolism
Nerve Tissue Proteins / metabolism
Norepinephrine Plasma Membrane Transport Proteins
Receptors, Presynaptic / drug effects*
Selective Serotonin Reuptake Inhibitors / pharmacology
Serotonin Plasma Membrane Transport Proteins
Symporters / metabolism

Substances

Adrenergic Uptake Inhibitors
Antidepressive Agents
Carrier Proteins
Dopamine Plasma Membrane Transport Proteins
Membrane Glycoproteins
Membrane Transport Proteins
Nerve Tissue Proteins
Norepinephrine Plasma Membrane Transport Proteins
Receptors, Presynaptic
SLC6A2 protein, human
SLC6A4 protein, human
Serotonin Plasma Membrane Transport Proteins
Serotonin Uptake Inhibitors
Symporters